Danfysik, one of the leading manufacturers of particle accelerators and Siemens Medical Solutions (Med), have entered into a cooperation contract for particle therapy solutions. The contract covers the exclusive delivery of accelerator systems by Danfysik to Siemens and the installation for medical applications. Danfysik’s accelerator systems include proton and carbon sources, synchrotron accelerators as well as beam delivery systems to the medical treatment rooms.

 

Danfysik will produce the accelerator systems jointly developed by both companies. Siemens will integrate the accelerator systems from Danfysik into its particle therapy systems developed for worldwide distribution. Both company profiles are highly complementary: State-of-the-art medical engineering and comprehensive knowledge in the area of clinical workflow are the core business of Siemens. Siemens will be adding accelerator technology know-how in medicine from its cooperation with GSI (Gesellschaft für Schwerionenforschung; the German Heavy Ion Lab). Since 1964, Danfysik has been successfully engaged in the industrial and scientific arena, and enjoys a world-renowned reputation for its expertise in accelerator technology.

With this partnership, Siemens Medical Solution will intensify its strong position in oncology and will be the first provider of standardized solutions for particle therapy with protons and carbon ions in one system. Particle therapy is a highly precise and biologically effective therapy. Using an accelerator system, protons or carbon ions, accelerated to a very high-speed level, are delivered into the tumour where they cause irreparable damage to the tumour cells. Surrounding tissue is spared since the tumour can be treated in a highly localized manner with an accuracy to the millimetre.

"We are excited to enter this new agreement as a supplier of the accelerator systems for Siemens' state-of-the-art Particle Therapy," says Bjarne Roger Nielsen, Managing Director of Danfysik. "This will further advance our accelerator systems and component technology to the benefit of all customers".

"We will continue to increase our capacity and resources to respond to the demands of our customers in basic research, industry as well as in health care."

For more information, please contact Lars Anthon at la@danfysik.dk

Siemens Medical Solutions particle therapy website: www.medical.siemens.com

More information about Particle Therapy: